FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091211700> ?p ?o ?g. }

• W2091211700 endingPage "383" @default.
• W2091211700 startingPage "373" @default.
• W2091211700 abstract "The biological response modifier OK-432 has been shown both to exert the enhancement of several immunological activities and to have a direct anti-tumor effect. The present study examines the immunopotentiating effect of OK-432 on peripheral blood monocytes (PBM) derived from normal humans. Monocyte activation was assessed by examining direct cell-mediated cytotoxic activity (CMC) and secretion of cytotoxic factors in the supernatant by the 51Cr release assay and secretion of tumor necrosis factor (TNF)-α detected by a sensitive radioimmunoassay. The OK-432-augmented activity was compared to that achieved by recombinant interferonγ-(rIFN-γ). Coculture of PBM with OK-432 overnight resulted in significant augmentation of CMC and secretion of cytotoxic factors and TNF in the supernatant. The effects observed were dose dependent and the resulting activity was much more pronounced than that achieved with an optimal concentration of IFN-γ. The monocyte- and supernatant-mediated cytotoxic activities were in a large part attributed to TNF as both activities were inhibited by anti-TNF antibody. Several parameters of monocyte activation by OK-432 were examined. The kinetics of monocyte activation revealed that a short time exposure (2–6 hr) was sufficient for activation but maximal activation was detected after 18 hr. However, the kinetics of the cytotoxic assay were not shortened and 16–20 hr was necessary for optimal cytotoxic activity. Significant synergy was obtained when suboptimal concentrations of OK-432 and IFN-γ were used. The synergy was noted in CMC, supernatant activity, and TNF concentration. These results demonstrate that OK-432 is a potent activator of monocyte cytotoxicity and also activates secretion of TNF. Also, OK-432 is a much more potent activator than rIFN-γ. The synergy with OK-432 and IFN-γ suggests that OK-432-mediated activation of monocytes takes place by a different mechanism than that mediated by rIFN-γ. Thus, monocytes and products thereof may actively participate in the in vivo anti-tumor effect mediated by OK-432." @default.
• W2091211700 created "2016-06-24" @default.
• W2091211700 creator A5055490703 @default.
• W2091211700 creator A5078964963 @default.
• W2091211700 date "1989-10-01" @default.
• W2091211700 modified "2023-09-24" @default.
• W2091211700 title "Activation of human peripheral blood-derived monocytes by OK-432 (Streptococcus pyogenes): Augmented cytotoxicity and secretion of TNF and synergy with rIFN-γ1" @default.
• W2091211700 cites W1506970964 @default.
• W2091211700 cites W1511533680 @default.
• W2091211700 cites W1619723454 @default.
• W2091211700 cites W1691371551 @default.
• W2091211700 cites W1998771014 @default.
• W2091211700 cites W2036533077 @default.
• W2091211700 cites W2047344874 @default.
• W2091211700 cites W2066177337 @default.
• W2091211700 cites W2101835477 @default.
• W2091211700 cites W2133764756 @default.
• W2091211700 doi "https://doi.org/10.1016/0008-8749(89)90297-9" @default.
• W2091211700 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2507170" @default.
• W2091211700 hasPublicationYear "1989" @default.
• W2091211700 type Work @default.
• W2091211700 sameAs 2091211700 @default.
• W2091211700 citedByCount "9" @default.
• W2091211700 crossrefType "journal-article" @default.
• W2091211700 hasAuthorship W2091211700A5055490703 @default.
• W2091211700 hasAuthorship W2091211700A5078964963 @default.
• W2091211700 hasConcept C109316439 @default.
• W2091211700 hasConcept C134018914 @default.
• W2091211700 hasConcept C153911025 @default.
• W2091211700 hasConcept C154317977 @default.
• W2091211700 hasConcept C176685330 @default.
• W2091211700 hasConcept C17991360 @default.
• W2091211700 hasConcept C185592680 @default.
• W2091211700 hasConcept C202751555 @default.
• W2091211700 hasConcept C203014093 @default.
• W2091211700 hasConcept C2781184567 @default.
• W2091211700 hasConcept C49039625 @default.
• W2091211700 hasConcept C55493867 @default.
• W2091211700 hasConcept C86803240 @default.
• W2091211700 hasConceptScore W2091211700C109316439 @default.
• W2091211700 hasConceptScore W2091211700C134018914 @default.
• W2091211700 hasConceptScore W2091211700C153911025 @default.
• W2091211700 hasConceptScore W2091211700C154317977 @default.
• W2091211700 hasConceptScore W2091211700C176685330 @default.
• W2091211700 hasConceptScore W2091211700C17991360 @default.
• W2091211700 hasConceptScore W2091211700C185592680 @default.
• W2091211700 hasConceptScore W2091211700C202751555 @default.
• W2091211700 hasConceptScore W2091211700C203014093 @default.
• W2091211700 hasConceptScore W2091211700C2781184567 @default.
• W2091211700 hasConceptScore W2091211700C49039625 @default.
• W2091211700 hasConceptScore W2091211700C55493867 @default.
• W2091211700 hasConceptScore W2091211700C86803240 @default.
• W2091211700 hasIssue "2" @default.
• W2091211700 hasLocation W20912117001 @default.
• W2091211700 hasLocation W20912117002 @default.
• W2091211700 hasOpenAccess W2091211700 @default.
• W2091211700 hasPrimaryLocation W20912117001 @default.
• W2091211700 hasRelatedWork W101529134 @default.
• W2091211700 hasRelatedWork W1489200483 @default.
• W2091211700 hasRelatedWork W1596543460 @default.
• W2091211700 hasRelatedWork W1691371551 @default.
• W2091211700 hasRelatedWork W170890397 @default.
• W2091211700 hasRelatedWork W1951190018 @default.
• W2091211700 hasRelatedWork W2013197070 @default.
• W2091211700 hasRelatedWork W2068502618 @default.
• W2091211700 hasRelatedWork W2170317207 @default.
• W2091211700 hasRelatedWork W261645828 @default.
• W2091211700 hasVolume "123" @default.
• W2091211700 isParatext "false" @default.
• W2091211700 isRetracted "false" @default.
• W2091211700 magId "2091211700" @default.
• W2091211700 workType "article" @default.